Sage Therapeutics shares owned by Assenagon Asset Management
Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by Assenagon Asset Management
from 13F filings
Historical chart of Assenagon Asset Management investment in Sage Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sage Therapeutics held by Assenagon Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sage Therapeutics by Assenagon Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $2.9M | 157k | 18.74 |
| 2023-12-31 | $293k | 14k | 21.67 |
| 2023-06-30 | $1.5M | 33k | 47.02 |
| 2023-03-31 | $4.4M | 104k | 41.96 |
| 2022-12-31 | $3.7M | 97k | 38.14 |
| 2022-09-30 | $3.8M | 97k | 39.16 |
| 2022-06-30 | $5.6M | 175k | 32.30 |
| 2021-09-30 | $1.4M | 32k | 44.32 |
| 2021-06-30 | $1.3M | 24k | 56.79 |
| 2021-03-31 | $1.2M | 16k | 74.87 |
More positions owned by Assenagon Asset Management
View all positions for Assenagon Asset Management